Chiba, Japan

Masahiro Uchino

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Order-Made Medical Research Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Uchino. Retrieved from https://idiyas.com/inventor/masahiro-uchino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Uchino: Innovator in Antibody Production

Introduction

Masahiro Uchino is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of medical research, particularly in the development of methods for antibody production. His innovative approach aims to enhance the efficiency and effectiveness of antibody preparation.

Latest Patents

Uchino holds a patent for a method of producing an antibody using a cancer cell. This invention provides a novel technique for preparing an antibody-producing cell, which includes several critical steps. The method is designed to streamline the process of antibody preparation, making it more accessible for medical applications.

Career Highlights

Masahiro Uchino is associated with Order-Made Medical Research Inc., where he continues to advance his research in antibody production. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

Uchino has collaborated with notable colleagues, including Hiroyuki Satofuka and Shingo Hanaoka. These partnerships have contributed to the development of innovative solutions in the field of medical research.

Conclusion

Masahiro Uchino's contributions to antibody production exemplify the importance of innovation in medical research. His work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…